LeonaBio (LONA) Equity Ratio (2019 - 2026)

LeonaBio (LONA) has 8 years of Equity Ratio data on file, last reported at 0.69 in Q1 2026.

• Quarterly Equity Ratio fell 19.72% year-over-year to 0.69 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.69 (down 19.72% YoY) and the FY2025 annual result came in at 0.3, down 60.47% from the prior year.
• Equity Ratio grew to 0.69 in Q1 2026 per LONA's latest filing, from 0.3 in the prior quarter.
• Across five years, Equity Ratio topped out at 0.96 in Q1 2022 and bottomed at 0.3 in Q4 2025.
• The 5-year median for Equity Ratio is 0.86 (2025), against an average of 0.82.
• Peak annual rise in Equity Ratio reached 33.58% in 2025, while the deepest fall reached 60.47% in 2025.
• Tracing LONA's Equity Ratio over 5 years: stood at 0.91 in 2022, then retreated by 10.8% to 0.81 in 2023, then retreated by 6.1% to 0.76 in 2024, then sank by 60.47% to 0.3 in 2025, then surged by 128.37% to 0.69 in 2026.
• Per Business Quant, the three latest LONA Equity Ratio figures stand at 0.69 (Q1 2026), 0.3 (Q4 2025), and 0.89 (Q3 2025).

Peer Comparison